LONDON, May 18, 2011 /PRNewswire-USNewswire/ -- WomanCare Global announced a plan today to restructure the organization undera newly created UK-based charity called WomanCare Global International. The restructure will be fully operational 1 July, 2011.
WomanCare Global International will identify innovative and high-quality products that will benefit women in the developing world, obtain the necessary product rights and licensing agreements, and seek foundation/donor funding and grants to support its mission. Continuing its existing hybrid business model, WomanCare Global International's new subsidiary company, Devapharma Trading, LTD., will be responsible for all product-related activities including: global sales, regulatory standards, quality assurance, pharmacovigilance, medical affairs, logistics and supply chain management, and product commercialization. WomanCare Global LLC will maintain its existing presence in the United States serving as WomanCare Global International's non-profit arm.
Saundra Pelletier, Chief Executive Officer of WomanCare Global International, will also serve as a Director of Devapharma Trading, LTD.
"We are very excited about the strategic evolution of our organization and look forward to the continued success of our unique hybrid model that allows us the flexibility to cross-subsidize quality reproductive healthcare products," said Saundra Pelletier, WomanCare Global's Chief Executive Officer. "This will ultimately give women in the developing world better access to safe, affordable and effective reproductive health choices."
About WomanCare Global International
WomanCare Global International, a UK-based charity, seeks to significantly impact the lives of women by providing access to affordable, quality reproductive health products. The organization believes that any woman, no matter where she lives, should have control over her reproductive health and family planning needs, ultimately improving her ability to care for herself and her family. WomanCare Global International strives to close the gaps between the availability of products in developing countries versus the developed world by creating a sustainable supply of effective options that will contribute to the safety, security and stability of women and their families. WomanCare Global International continues to add products to its expanding portfolio, and—through its subsidiary Devapharma—makes products available in more than 110 countries, with particular focus on under-served markets in Africa, Asia and Latin America.
About Devapharma, a WomanCare Global International Company
Devapharma, a WomanCare Global International company, specializes in the efficient and reliable delivery of quality reproductive health products and plays a critical role in fulfilling WomanCare Global International's mission to help women manage their reproductive health and family planning needs. Devapharma has regulatory and quality departments that assure adherence to regulatory requirements and global quality standards, and also provides a comprehensive global sales, marketing and distribution channel. Devapharma delivers products to both public and private sectors via an established global supply chain reaching more than 110 countries.
SOURCE WomanCare Global International
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All